Browsing Linhardt Research Labs Papers by Author "Nash, Kelly"

Now showing items 1-1 of 1

Glycolipid-containing nanoparticle vaccine engages invariant NKT cells to enhance humoral protection against systemic bacterial infection but abrogates T-independent vaccine responses

Shute, Travis; Amiel, Eyal; Alam, Noran; Yates, Jennifer L.; Mohrs, Katya; Dudley, Elizabeth; Salas, Briana; Mesa, Chloe; Serrata, Adriana; Angel, Daniel; Vincent, Brandy K.; Weyers, Amanda; Lanthier, Paula A.; Vomhof-Dekrey, Emilie; Fromme, Rachel; Laughlin, Mitchell; Durham, Olivia; Miao, Jianjun; Shipp, Devon; Linhardt, Robert J.; Nash, Kelly; Leadbetter, Elizabeth A. (2021-04-15)

CD4+ T cells enable the critical B cell humoral immune protection afforded by most effective vaccines. We and others have recently identified an alternative source of help for B cells in mice, invariant NK T (iNKT) cells. ...